Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Synonyms
DA-1229 tartrate
Description
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.